Tag: ebola

The Truth About Ebola

There have been a plethora of headlines promoting “new” virus narratives in 2026 after the COVID-19 fraud has taken a back seat. Now, fresh narratives involving hantavirus have been launched or at least relaunched after earlier episodes. Additionally, subplots have included perennial viruses such as influenza, measles and the previously dreaded HIV.

However, none of these stories stir up the same fear as Ebola, which is now being featured in the latest campaign. This is because people have been conditioned to believe that fever, bleeding from the eyes and a 50% death rate is the result of a highly-contagious “virus”. And while previous “outbreaks” have been limited to the Third World, the latest push involves the threat of much further spread.

We have exposed the anatomy of the fake COVID pandemic many times, including non-sensical case definitions and meaningless statistics. While we have covered Ebola previously, particularly in ‘Bioweapons BS‘, this is our first presentation completely dedicated to the topic. In this video we examine its history, whether anything new is actually happening and how best to respond to this latest situation.

Keep reading

CDC expands Ebola screenings to New York’s JFK airport

The Centers for Disease Control and Prevention has expanded its passenger screening for Ebola to John F. Kennedy International Airport in New York.

The federal agency said the expansion of its around-the-clock Port Health Protection system went into effect at Kennedy airport Thursday night. 

 The CDC also said Kennedy previously conducted enhanced public health entry screening and has established operational procedures in place.

The enhanced screening” is also now underway at Washington Dulles International Airport, Hartsfield-Jackson Atlanta International Airport and the George Bush Intercontinental Airport, in Houston, for air passengers arriving from the Democratic Republic of the Congo, South Sudan and Uganda. 

“Public health entry screening serves as one component of CDC’s layered public health approach, which also includes overseas exit screening, airline illness reporting, and post-arrival public health monitoring,” the CDC said in a post on X.

The State Department issued a travel advisory recently, instructing all U.S.-bound American citizens and lawful permanent residents who have been in the DRC, Uganda or South Sudan within 21 days of arrival in the U.S. to go through the “enhanced public health screening” carried out by the CDC and U.S. Customs and Border Protection.

The screenings come ahead of the 2026 FIFA World Cup, which is scheduled to take place in the United States, Canada and Mexico next month. The first match will take place in Mexico City on June 11.

The United States has not seen an Ebola case so far, though one American tested positive for the virus while overseas and is being treated in Germany.

Keep reading

Kenyan Court Rejects Plan For US Ebola Quarantine Center Amid Growing Outbreak

A day after US officials said Kenya had approved a request to open a quarantine center for Americans exposed to a rare strain of the Ebola virus, a court in the East African nation on Friday temporarily blocked the plan amid a growing outbreak in neighboring Uganda and the Democratic Republic of Congo.

The High Court prohibited the Kenyan government from establishing or operating any Ebola exposure, quarantine, isolation, or treatment facility in the country under any agreement with the United States or any other foreign government or agency.

The court also blocked Kenya’s government from allowing anyone infected with or exposed to Ebola into the country pending the outcome of the case, which was filed by the Katiba Institute, a civil rights group.

“At its core, the case is about preserving constitutional accountability, protecting public health, and ensuring that no government may place expediency above the lives and safety of the people of Kenya,” Katiba Institute executive director Nora Mbagathi said Thursday.

A 50-bed Ebola quarantine center was set to open Friday at Laikipia Air Base in Nanyuki, located approximately 125 miles north of Nairobi. The facility would have been operated by members of the US Public Health Service, a uniformed branch of the Department of Health and Human Services.

US Secretary of State Marco Rubio said Thursday during a Cabinet meeting that “we cannot and will not allow any cases of Ebola to enter the United States.”

However, US public health officials strongly criticized the plan to quarantine Americans in Kenya instead of repatriating them, with one emergency physician accusing the Trump administration of “a dramatic abdication of what we owe our own.”

Elected leaders in Laikipia County welcomed the High Court’s ruling. They had opposed the US quarantine center, and had asked in a joint statement prior to the decision, “Why Laikipia?”

“What does the US government know about this that they are not accepting their own affected citizens into their soil but are ready to have them elsewhere?”

The Kenya Medical Practitioners, Pharmacists, and Dentists Union (KMPDU), which had strongly opposed the quarantine center and had threatened to strike, also welcomed the High Court ruling.

“We are utterly disgusted by the government’s apparent willingness to trade national biosecurity and the lives of its citizens for foreign aid,” KMPDU secretary general Davji Bhimji Attelah said in a statement Thursday, referring to the $13.5 million the Trump administration pledged for Ebola preparedness in Kenya, part of a broader $125 million US commitment toward fighting the disease.

“We will not sit back and watch Kenya be treated as a containment colony for a lethal pathogen that we did not generate,” Attelah added. “We will not tolerate an apartheid healthcare model on Kenyan soil. If it is too dangerous for America, it is too dangerous for Kenya.”

Critics say President Donald Trump’s ideologically driven decision to withdraw the US from the World Health Organization (WHO), his administration’s dismantling of the US Agency for International Development, and reduced funding for the US Centers for Disease Control and Prevention’s global public health efforts have adversely affected the response to the current Ebola epidemic, compared with 2014 and 2019 outbreaks.

Keep reading

Ebola Was Identified Nearly 50 Years Ago — Why Are There No Treatments for the Latest Outbreak?

As health officials work to contain a growing Ebola outbreak in Central Africa, questions are resurfacing about why some strains of the virus still lack approved treatments nearly 50 years after Ebola was first identified.

The World Health Organization (WHO) has reported 900 suspected infections and 220 deaths through ongoing transmission of the Ebola virus in parts of the Democratic Republic of Congo (DRC) and Uganda.

The agency warned that outbreaks in conflict-affected and resource-deprived regions can escalate quickly if containment efforts falter.

The virus was first discovered in 1976 near the Ebola River in Zaire, now the DRC. Licensed vaccines such as Merck’s Ervebo have since shown strong protection against the Zaire strain of Ebola, responsible for major outbreaks in West Africa from 2014-2016 and the DRC from 2018-2020.

However, no approved vaccine or specific antiviral treatment yet exists for the Bundibugyo strain, which is responsible for the latest outbreak.

Public health experts say the gap reflects long-standing research priorities that have centered on the most extensive and lethal Ebola variants, leaving less common strains with fewer medical remedies.

Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security in Baltimore, Maryland, said Ebola vaccine development initially focused on the Zaire strain due to both its outbreak history and biodefense interest.

“Vaccines targeted to the Zaire species of Ebola were developed first because this species was the most common form of Ebola and also was the subject of Soviet bioweapons development efforts,” Adalja said.

“In recent years there have been programs developed to target the second most common form of Ebola, Sudan, and there is interest in Bundibugyo countermeasures as well.”

James Lyons-Weiler, Ph.D., author of “Ebola: An Evolving Story,” said any countermeasures taken to combat Bundibugyo have lagged due to delayed diagnostics and overall lack of preparedness.

“Everyone pretends the pathogen surprised them,” Lyons-Weiler said. “Bundibugyo did not appear from nowhere. The time to act is before, not after.”

Keep reading

Metallic nanoparticles in vaccines can be activated by frequencies, and then they could say there is an Ebola outbreak

In June 2025, Dolores Cahill, formerly Professor of Translational Science at the University College Dublin School of Medicine, Principal Investigator at the Conway Institute of Biomolecular & Biomedical Research and vice chair of the Scientific Committee of the Innovative Medicines Initiative, and founding member of World Doctors Alliance, participated in the ‘Medical Doctors for Covid Ethics International’ webinar moderated by Charles Kovess.

Medical Doctors for Covid Ethics International (“MD4CE International”), founded by UK medical whistle-blower Dr. Stephen Frost, is a global organisation composed of doctors, scientists, lawyers, journalists, economists, historians, politicians, philosophers, data analysts, bankers, military/intelligence experts and other professionals from across the world who advocate for medical ethics, patient safety and human rights in the context of the covid pandemic.

“[There are] … titanium, steel, barium nanoparticles [in vaccines]. And … those nanoparticles get into our organs [and] can be affected by radiation … they can modulate the frequency … [to cause] nosebleeds …[and] say there is an Ebola outbreak,” Prof. Cahill said.

You can watch the full webinar on Rumble HERE.

Note: We can’t be certain of the specific 2017 Italian study Prof. Cahill was referring to in the video clip (also see below), but there is THIS one, which is relevant.  Read: All tested vaccines reveal toxic substances linked to autoimmune disease, Natural Health 365, 6 April 2018

In the clip above, Prof. Cahill said:

Because the nanoparticle and the radiation. I did publications on nanoparticles when I was researching. And there’s a publication from 2017, with an Italian professor showing that there were, she tested 40 different vaccines, 39 vaccines for human babies, adults and one for cats. And she showed all these metal or titanium, steel, barium nanoparticles. And it is those nanoparticles that get into our organs that can be affected by radiation.  Exactly what you’re saying. 

Now, when I gave evidence after 9-11 [in] 2001, right. I ran one of the so-called biosafety labs deliberately to get access to the information. And I gave evidence about the threats to people in Congress in October 2001. I was going through what was going to happen in the injections with fertility, with the peptides. And then I mentioned the nanoparticles, and the military said shut up and sit down. Right. Because obviously they didn’t want to. So, I was saying the threat isn’t these things flying into, it’s what’s going to be in the food and the vaccine, but particularly the nanoparticles.

I’m only mentioning that because within the system, everybody knew. But one of the major detoxes is it is possible to detox from the nano. It’s, you know, mainly not all of them, but what I was studying 20 years ago is that they can just modulate the frequency and that say if 40-year-olds or 20-year-olds have a specific metal in their organ, that can be, you know, in a university campus or it can be in a school, and there could be like where people have nosebleeds. Right? Because that’s why they rolled out the injections in different batches and different age groups.

And literally they could do that all across one or two countries and then wake up in the morning, you could have nosebleeds or serious deaths of teenagers. But then they could say there is an Ebola outbreak. Do you get it? Because there are different nanoparticles that resonate. So, it’s very specific. And I think some of the people that are being targeted to be seriously ill can be easily targeted so that they just die. You know, we die in our sleep or we drop dead or whatever. And I think it’s that kind of technology. So, it is a huge threat.

This is reminiscent of what American attorney Todd Callender and the late Dr. Rashid Buttar had previously warned about nanoparticles in vaccines, once inside the body, causing harm at a time that they will determine.

Keep reading

UK Scientists Rushing to Create Ebola Vaccine Using COVID Jab Technology

UK researchers are rushing to develop a new Ebola vaccine based on the exact same viral vector platform used in the Oxford/AstraZeneca COVID-19 jab.

The effort comes as a new outbreak of the Bundibugyo strain of Ebola continues to spread in the Democratic Republic of Congo.

The Oxford Vaccine Group (OVG) announced it is urgently producing its candidate vaccine, ChAdOx1 BDBV, which could enter human clinical trials in as little as two to three months if animal testing succeeds.

The Bundibugyo Ebolavirus is one of the less common but still highly lethal strains of Ebola.

Unlike the more frequently seen Zaire strain, there are currently no licensed vaccines or specific treatments approved for Bundibugyo virus disease.

The WHO and local authorities have described the situation as “spreading rapidly,” with contact tracing and quarantine efforts underway. However, the risk to the UK and broader Europe remains low, according to the European Centre for Disease Prevention and Control (ECDC).

The candidate vaccine is a monovalent (single-strain) ChAdOx1 BDBV vaccine specifically targeting the Bundibugyo Ebolavirus.

It uses the ChAdOx1 viral vector platform, the same chimpanzee adenovirus-based technology used for the Oxford/AstraZeneca COVID-19 vaccine.

Keep reading

First hantavirus, now Ebola; What happened to the 323 vials of viruses that went missing from an Australian laboratory?

This month, a hantavirus “outbreak” and an Ebola “outbreak” have been reported. 

The widely publicised hantavirus outbreak on the cruise ship MV Hondius was managed by the widely discredited World Health Organisation (“WHO”).  And WHO has declared the Ebola “outbreak” as a Public Health Emergency of International Concern (“PHEIC”).

This has reminded us of an article we published at the end of 2024 about virus samples that went missing from an Australian laboratory.  So, we are republishing it below.

In 2021, 323 vials of virus samples went missing from a government-operated laboratory in Queensland, Australia. Two of the vials contained hantavirus.

Hantavirus is one of the viruses that causes illnesses referred to as viral haemorrhagic fevers (“VHFs”).   Another virus that causes VHFs is the Ebolavirus.

Update: An investigation was carried out into the missing vials of viruses by the Queensland Ministry of Health, which determined they were likely destroyed rather than stolen or lost.  According to a “fact check” blog by Snopes, “the agency said the samples were unlikely to have been lost or stolen, and were instead unaccounted for due to incomplete lab records, adding that the breach caused ‘no risk or harm’ to staff or the broader community.”

According to the Mirror, “questions have surfaced over [the missing vials] location following the deadly virus infecting passengers aboard the MV Hondius cruise ship.”

Interestingly, 323 missing vials of “live” virus did not attract the attention of an international response that required WHO’s management, but suspected cases of hantavirus on a cruise ship did.

Just as interesting is that missing vials of “live” virus posed no risk to the public at large, but a few suspected cases of “the deadly” hantavirus on a cruise ship, which is not transmitted between people, did.

Keep reading

Former CDC director on Ebola outbreak: ‘I suspect this is going to become a very significant pandemic’

Former Centers for Disease Control and Prevention (CDC) Director Robert Redfield said Wednesday he suspects the spreading Ebola outbreak in Africa will spread across three new countries and become a “very significant pandemic.”

“I suspect this is going to become a very significant pandemic, probably going to leak into Tanzania, leak into southern Sudan, maybe leak into Rwanda,” Redfield said during an appearance on NewsNation’s “Elizabeth Vargas Reports.” 

“So, it’s going to be very disruptive,” he added. 

A majority of the Ebola cases are in Congo and Uganda. 

Local health officials in the two nations reported 536 suspected cases, 105 probable cases, 34 confirmed cases and around 134 suspected deaths from the outbreak, according to the CDC.

“This is an outbreak right now that is really a significant outbreak that’s of significant public health international concern, partially because what you said, it wasn’t recognized very quickly. I’m not sure why,” Redfield told anchor Elizabeth Vargas. 

“Normally when we have these Ebola outbreaks, and I had three of them when I was CDC director, all of which were in the DRC, normally we recognize them when we have five, 10 cases, you know, at most,” he continued. “This one really wasn’t picked up until there was over 100 cases.”

The former CDC director added, “As you said, now there’s over 500 cases. There’s close to 150 deaths already, and it’s moving very rapidly.”

The May outbreak marks the 17th outbreak of Ebola in the region within the past 50 years, and officials said the most recent outbreak ended last December, the CDC noted.

One American worker reportedly came in contact with the virus while working in Congo and was transported to Germany for treatment.

Keep reading

SURPRISE: Moderna began work on Ebola mRNA vaccine just months ago

Well, what do we have here?

Not long ago I reported on how the vaccine maker Moderna had in fact begun development of an mRNA vaccine against hantavirus already in 2024.

What is also interesting is how they had a patent on a particular sequence that happened to also be in the covid virus. And this particular sequence is actually what made it unique and very infectious to humans. They got this patent years before the outbreak of covid.

Now, guess what?

The WHO has just declared a global health emergency over the Ebola outbreak that has happened in Africa.

Now the mainstream media has gone into full panic mode over Ebola, and it seems like the previous fearmongering over hantavirus just disappeared almost overnight.

Guess what I found?

Turns out that just some months ago Moderna began development of a new mRNA vaccine against Ebola with $26.7 MILLION in funding from an organization called CEPI.

This together with Oxford University who is also creating an Ebola vaccine on the same platform as the AstraZeneca covid vaccine.

Guess who is a major backer of this CEPI organization?

Bill Gates of course.

So what is going on?

Oh, and AI will be used to help develop this new Ebola vaccine to trigger a strong immune response.

Keep reading

Chinese scientists create 90% lethal Ebola-like virus to study eye disorders

Chinese scientists have genetically modified a virus that imitates Ebola infection. This virus has caused severe eye ulcers and ultimately wiped out an entire group of hamsters.

Researchers are hopeful that this study will aid in the research of Ebola-related eye disorders.

In this study, vesicular stomatitis, typically found in livestock, was harboring the Ebola virus. When they gave it to the hamsters, the entire group died after the ulcers in their eyes worsened.

New model reveals promising insights into Ebola virus research

Vesicular stomatitis (VSV), carries a part of the Ebola virus called glycoprotein (GP). It helps the virus to enter and infect the cells. Five female and five male hamsters that were up to three weeks old died within three days.

They showed symptoms similar to those in Ebola patients, such as weight loss, multi-organ failure, severe eye inflammation, and ulcers. Additionally, the hamsters had high levels of the virus in their bodies.

Scientists are optimistic that this new model could help in future research on Ebola-related eye disorders. “All animals died within 2-3 days after infection,” the researchers observed, noting that this model could be useful for testing Ebola vaccines.

According to the scientists, this model allowed for quick preclinical testing of Ebola virus countermeasures in BSL-2 conditions.

They added, “This surrogate model is a safe, effective, and cost-efficient tool for rapid preclinical evaluation of medical countermeasures against the Ebola virus under BSL-2 conditions. It has the potential to accelerate technological advances and breakthroughs in combating Ebola virus disease.”

More accessible to researchers for studying

The Ebola virus causes internal bleeding and tissue damage and is spread by direct contact with infected body fluids, such as blood or sweat, or by touching contaminated objects. This is significant because studying Ebola requires expensive and high-level biological security, like that in BSL-4 facilities.

As a result, the virus has been less accessible to scientists. According to the scientists, the development of countermeasures against EBOV has been hindered by the lack of ideal animal models. The reason was that EBOV requires handling in BSL-4 facilities.

In the study, they also analyzed the influence of the virus. They found that the virus had accumulated in critical tissues. Like for example the heart, lungs, liver, spleen, kidneys, intestines, and brain. As the study showed, the highest viral loads were found in the liver, and the lowest levels were found in the brain.

Keep reading